合成生物學市場規模、佔有率和成長分析：按工具、技術、應用和地區分類 - 產業預測，2024-2031 年

2022年全球合成生物學市場規模將為113億美元，從2023年的141.8億美元成長到2031年的872.7億美元，預計在預測期（2024-2031年）複合年成長率為25.5%。

合成生物學市場預計在未來幾年將出現強勁成長，這主要是由技術創新和對永續替代品需求不斷成長的推動。基因編輯技術（特別是 Cas9 和 CRISPR）的重大進步，以及合成基因合成的改進，正在使合成生物學應用更有效率和更具成本效益。隨著環境問題和永續性的日益突出，人們對綠色化學品、生物分解性材料和生質燃料等永續解決方案的興趣日益濃厚，進一步推動了這一趨勢。然而，它面臨著倫理和監管障礙帶來的挑戰，包括基因改造、環境影響和生物安全爭論，這可能會阻礙商業化和正在進行的研究舉措。儘管有這些障礙，樂觀情緒仍然存在。特別是，先進治療和個人化醫療的出現有望透過解決以前無法治療的疾病來徹底改變醫療保健。因此，合成生物學市場正處於十字路口，技術進步和社會需求推動創新，而法律規範也不斷發展以解決倫理問題。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 專利分析
• 價格分析
• 監管分析
• 價值鏈分析
• 市場生態系統
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

合成生物學市場：依工具分類

• 市場概況
• 寡核苷酸/合成DNA
• 酵素
• 克隆技術套件
• 合成細胞
• 底盤有機體
• 異源核酸

合成生物市場：依技術分類

• 市場概況
• 基因合成
• 基因組工程
• 定序、生物資訊學
• 特異性誘變
• 複製
• 測量/建模
• 微流體
• 奈米科技

合成生物市場：依應用分類

• 市場概況

合成生物學市場規模：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 義大利
  • 法國
  • 英國
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• [if!supportLists][endif]Thermo Fisher Scientific, Inc.（US）
• Merck KGaA（Germany）
• Agilent Technologies（US）
• Novozymes（Denmark）
• Ginkgo Bioworks（US）
• Amyris（US）
• Precigen, Inc.（US）
• GenScript（China）
• Twist Bioscience（US）
• Synthetic Genomics（US）
• Codexis, Inc.（US）
• Synthego（US）
• Creative Enzymes（US）
• Eurofins Scientific（Luxembourg）
• Bota Biosciences Inc.（China）
• Creative Biogene（US）
• Enbiotix, Inc.（US）
• Illumina, Inc.（US）
• New England Biolabs（US）
• Pareto Bio, Inc.（US）

Global Synthetic Biology Market size was valued at USD 11.3 Billion in 2022 and is poised to grow from USD 14.18 Billion in 2023 to USD 87.27 Billion by 2031, at a CAGR of 25.5% over the forecast period (2024-2031).

The synthetic biology market is poised for robust growth in the coming years, driven largely by technological innovations and an increasing demand for sustainable alternatives. Key advancements in gene editing technologies, particularly Cas9 and CRISPR, along with improvements in synthetic gene synthesis, are enhancing the efficiency and cost-effectiveness of synthetic biology applications. This is further fueled by the rising interest in sustainable solutions, such as green chemicals, biodegradable materials, and biofuels, as environmental concerns and the push for sustainability gain prominence. However, the market faces challenges stemming from ethical and regulatory hurdles, including debates over genetic modifications, environmental impacts, and biosafety, which may hinder both commercialization and ongoing research initiatives. Despite these obstacles, the landscape remains optimistic, particularly with the emergence of advanced therapies and personalized medicine, which hold the promise to revolutionize healthcare by addressing previously untreatable conditions. As such, the synthetic biology market stands at a crossroads, with technological progress and societal demands pushing for innovation, while regulatory frameworks evolve to address ethical considerations.

Top-down and bottom-up approaches were used to estimate and validate the size of the global synthetic biology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

global synthetic biology Market Segmental Analysis

The Global Synthetic Biology Market is segmented by Tool, Application, Technology, and Region. Based on Tool, the market is segmented into Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technologies Kits, Synthetic Cells, Chassis Organisms, and Xeno-Nucleic Acids. Based on Application, the market is segmented into Medical Application, Pharmaceuticals, Drug Discovery and Therapeutics, Other Medical Application, Artificial Tissue and Tissue Regeneration, Industrial Applications, Other Industries, Food & Agriculture, Environmental Applications. Based on Technology, the market is segmented into Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Site-directed Mutagenesis, Cloning, Measurement and Modelling, Microfluidics, and Nanotechnology. By Region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America.

Driver of the global synthetic biology Market

The global synthetic biology market is being significantly driven by the advancements in healthcare and agriculture, where innovative therapies, diagnostics, and vaccines are being developed at an unprecedented pace. The ability of synthetic biology to engineer microorganisms and plants has revolutionized the pharmaceutical sector, enabling the rapid production of targeted treatments and improved diagnostics. Simultaneously, in agriculture, genetically tailored crops designed for enhanced resistance against diseases and pests contribute to greater agricultural productivity and food security, addressing critical global challenges. This dual impact on healthcare and agriculture not only sparks market growth but also fosters broader societal benefits, thereby driving further investment and innovation in synthetic biology.

Restraints in the global synthetic biology Market

The high initial costs associated with the development of synthetic biology technologies serve as a significant market restraint for the global synthetic biology market. These financial barriers limit scalability and accessibility, particularly for smaller companies and emerging economies. Additionally, the complexities involved in engineering, designing, and integrating synthetic biological systems pose substantial challenges, potentially undermining the reliability and efficiency of these technologies. As a result, these factors could deter investment and innovation, slowing the overall growth of the market and limiting the effectiveness of synthetic biology solutions in addressing various biotechnological needs.

Market Trends of the global synthetic biology Market

The global synthetic biology market is increasingly trending towards the integration of epigenetic technologies, as new entrants strive to address the complexities of engineered gene expression. The dynamic interplay of epigenetics and DNA sequences often leads to inconsistent outcomes, prompting innovative solutions that enhance the reliability and predictability of synthetic constructs. Startups and established firms alike are leveraging advancements in epigenetic engineering to refine genetic modifications, ensuring better control over gene activity. This focus on epigenetics is expected to drive growth in the sector, as it enables developers to create more sophisticated and effective biotechnological applications across various industries.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Patent Analysis
• Pricing Analysis
• Regulatory Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Synthetic Biology Market by Tool

• Market Overview
• Oligonucleotides and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Synthetic Cells
• Chassis Organisms
• Xeno-nucleic Acids

Synthetic Biology Market by Technology

• Market Overview
• Gene Synthesis
• Genome Engineering
• Sequencing, Bioinformatics
• Site-directed Mutagenesis
• Cloning
• Measurement and Modelling
• Microfluidics
• Nanotechnology

Synthetic Biology Market by Application

• Market Overview

Synthetic Biology Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • Italy
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• [if !supportLists] [endif] Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amyris (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precigen, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twist Bioscience (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthetic Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codexis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Enzymes (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bota Biosciences Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biogene (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enbiotix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pareto Bio, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments